APOLLO is a national observational study. The purpose of this study is to test kidney donors and kidney transplant recipients for variants (or forms) of the apolipoprotein L1 gene (called APOL1) to determine whether they impact outcomes. APOLLO will follow individuals who receive a kidney from an eligible (living or deceased) kidney donor. In addition, APOLLO will follow individuals who donate a kidney to assess the impact of the APOL1 gene. This study is being done to improve outcomes after kidney donation and kidney transplantation.
APOLLO is coordinated by the Wake Forest School of Medicine and has 13 Network Hubs that will work with all of the transplant programs in the United States, including Puerto Rico.
Biosample Procedures for Transplant Programs
APOLLO Statement on Racial Injustice
Potential Participants and Community »
2022 Fall Participant Newsletter » (Spanish version)
2023 Spring Participant Newsletter » (Spanish version)
Publications and Presentations